Trial · NCT00098293
Adverse events1,060
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,060
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Maraviroc Once Daily + CBV (DB), Then Twice Daily + CBV (OL) | 12 | 174 | |
| other | Anaemia | Blood and lymphatic system disorders | Maraviroc Twice Daily + CBV (DB and OL) | 27 | 360 | |
| other | Anaemia | Blood and lymphatic system disorders | Efavirenz Once Daily + CBV (DB and OL) | 18 | 361 | |
| other | Anaemia | Blood and lymphatic system disorders | Maraviroc Twice Daily + CBV (SP) | 0 | 127 | |
| other | Conjunctivitis | Eye disorders | Maraviroc Once Daily + CBV (DB), Then Twice Daily + CBV (OL) | 11 | 174 | |
| other | Conjunctivitis | Eye disorders | Maraviroc Twice Daily + CBV (DB and OL) | 11 | 360 | |
| other | Conjunctivitis | Eye disorders | Efavirenz Once Daily + CBV (DB and OL) | 25 | 361 | |
| other | Conjunctivitis | Eye disorders | Maraviroc Twice Daily + CBV (SP) | 0 | 127 | |
| other | Abdominal distension | Gastrointestinal disorders | Maraviroc Once Daily + CBV (DB), Then Twice Daily + CBV (OL) | 12 | 174 | |
| other | Abdominal distension | Gastrointestinal disorders | Maraviroc Twice Daily + CBV (DB and OL) | 21 | 360 | |
| other | Abdominal distension | Gastrointestinal disorders | Efavirenz Once Daily + CBV (DB and OL) | 20 | 361 | |
| other | Abdominal distension | Gastrointestinal disorders | Maraviroc Twice Daily + CBV (SP) | 0 | 127 | |
| other | Abdominal pain | Gastrointestinal disorders | Maraviroc Once Daily + CBV (DB), Then Twice Daily + CBV (OL) | 30 | 174 | |
| other | Abdominal pain | Gastrointestinal disorders | Maraviroc Twice Daily + CBV (DB and OL) | 53 | 360 | |
| other | Abdominal pain | Gastrointestinal disorders | Efavirenz Once Daily + CBV (DB and OL) | 53 | 361 | |
| other | Abdominal pain | Gastrointestinal disorders | Maraviroc Twice Daily + CBV (SP) | 0 | 127 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Maraviroc Once Daily + CBV (DB), Then Twice Daily + CBV (OL) | 7 | 174 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Maraviroc Twice Daily + CBV (DB and OL) | 22 | 360 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Efavirenz Once Daily + CBV (DB and OL) | 23 | 361 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Maraviroc Twice Daily + CBV (SP) | 0 | 127 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00098293/events